1. Introduction {#sec0005}
===============

Cholesterol is an intensively studied, multi-functional lipid that is key to many aspects of immunological, neuronal, viral and hepatocyte biology. It is an essential component of cellular membranes and is a precursor to steroids, bile acids and oxysterols whilst its own precursors contribute to prenylation and dolichylation and the formation of vitamin D~3~. One of the oxysterols known to be involved in linking sterol metabolism to innate immunity [@bib0005; @bib0010] is 25-hydroxycholesterol. However its place in the sterol metabolism has not yet been well established.

Despite the importance of the cholesterol synthesis pathway to cellular function and its value in pharmaceutical therapies, an integrative picture of how the pathway is structured has not been well described in the literature, impeding the development of a more rigorous understanding of the role of the cholesterol metabolism in cellular processes. Publications typically focus on segments of the cholesterol biosynthesis pathway showing variable level of details. Kovacs and co-authors focus on the mevalonate section of the pathway and on the subcellular location of the enzymes involved [@bib0015]. Wang and co-authors concentrate on the steps leading to 24(S),25-epoxycholesterol synthesis and their similarity to steps in the cholesterol biosynthesis pathway [@bib0020]. Previous work studying the role of the cholesterol biosynthesis pathway has shown a modest level of detail on the sterol arms of the pathway [@bib0025; @bib0030; @bib0035] in innate immunity. The LIPID MAPS consortium offers the most detailed descriptions of the Bloch and Kandutsch-Russell branches of cholesterol biosynthesis, but these lack cell compartment information and lack integration with the 24(S),25-epoxycholesterol shunt arm and other branching pathways [@bib0040].

Here we present a comprehensive literature review of the cholesterol synthesis pathway and we implement this as a detailed pathway that captures enzymatic activity and compartmental localization and summarizes all intermediate metabolic forms. Our review also clearly indicates what information is missing and where additional research is required.

2. Materials and methods {#sec0010}
========================

The model of the cholesterol biosynthesis pathway presented in this work has been assembled using a variety of publicly available resources including the research findings of the LipidMaps consortium [@bib0040] and results obtained from thorough searches of the published literature that have been manually curated and validated by domain experts.

In cases where there were conflicting reports, preference was given to the more recent papers and to the works in which more reliable and advanced methods were used. The suggested order of events is supported by a number of independently obtained research results. The principles of the Evidence Ontology (ECO) [@bib0045], the Gene Ontology Evidence Codes [@bib0050] and the Evidence Code Decision Tree [@bib0055] were considered during the pathway reconstruction.

A brief summary is provided for each enzyme and the corresponding metabolic reactions involved in the pathway. For each enzyme we endeavored to capture the following information where available: corresponding gene name approved by HUGO Gene Nomenclature Committee [@bib0060], alternative names, enzymological activities according to the Enzyme Nomenclature Committee of the IUBMB [@bib0065], enzyme function description, subunit structure, subcellular location and related disorders.

We have included a list of UniProt IDs for the proteins captured in the model ([Table 1](#tbl0005){ref-type="table"}) and a list of metabolite names (common and systematic) as used in the LipidMaps database [@bib0040] ([Table 2](#tbl0010){ref-type="table"}). Common names are used on the map where available.

The pathway that we present here is described using the Systems Biology Graphical Notation (SBGN) [@bib0070], a community driven consensus graphical schema for capturing the molecular details of pathway systems. In particular, we use the SBGN Process Description language [@bib0075]. A machine-readable model is available as part of the supplementary material in SBGN-ML format [@bib0080] and we present it graphically in [Figs. 1--3](#fig0005 fig0010 fig0015){ref-type="fig"}, in an enhanced form. The SBGN-ML format files can be read using a variety of software packages.

In particular, the supplementary files provide a description of the pathway that can be edited and modified in accordance with the SBGN standard in order to be of future use to the research community. The SBGN-ML file format encodes the biological meaning associated with each component of the model. This allows the model to be parsed by software (i) to ensure that modification is biologically valid and (ii) to facilitate automatic generation of mathematical descriptions of the pathway biology. It should be possible to open these files in any software designed to comply with the SBGN-ML standard, including but not limited to VANTED and Cytoscape [@bib0085; @bib0090]. For the purpose of this review, we compiled and tested the files using the VANTED software tool [@bib0085]. Here we shall outline how the files can be opened and accessed using the VANTED and CYTOSCAPE [@bib0090] software tools.

2.1. Accessing supplementary SBGN-ML files using the VANTED software tool {#sec0015}
-------------------------------------------------------------------------

***2.1.1*** Download the files with '.sbgn' file extension from the supplementary material.***2.1.2*** Download and install VANTED from <http://vanted.ipk-gatersleben.de/>.***2.1.3*** Open VANTED and you will be greeted by a screen divided into two regions: an empty area on the left for diagrams and a column on the right containing settings under various tabs.***2.1.4*** Using the automated installer to obtain the SBGN-ML add-on.***2.1.4.1*** In the right hand column select the 'Help' tab and then the 'Settings' tab beneath and click on the 'Install/Configure Add-ons' button. This will open the Add-on Manager.***2.1.4.2*** Click on the 'Find Add-ons/Updates' button on the bottom of the Add-on Manager window. This, in turn, opens the 'Direct Add-on Download' window.***2.1.4.3*** At the top right of the Add-ons window, left and right arrows allow the user to move through a list of the available Add-ons. Find the Add-on entitled, 'SBGN-ED' and click the corresponding 'Install Add-on' button. VANTED will now automatically download the SBGN extension.***2.1.4.4*** Click 'OK' and you will return to the 'Add-on Manager' where 'SBGN-ED' will now be listed as an Add-on. Ensure that the Active button is ticked beside the SBGN-ED entry to the list.***2.1.4.5*** Click 'OK' on the 'Add-on Manager'. The software is now installed.***2.1.4.6*** From the menus at on the top of the VANTED window, select File\>Open and choose your downloaded file with the '.sbgn' file extension, in the usual way.***2.1.5*** Manual installing the SBGN-ML add-on***2.1.5.1** From* <http://vanted.ipk-gatersleben.de/> Select Add-ons and then 'SBGN-ED -- Editing, Translating and Validating of SBGN Maps'.***2.1.5.2*** Select 'Download & Installation' and then 'SBGN-ED' under downloads. A file called sbgn-ed.jar should start to download.***2.1.5.3*** Return to Vanted and in the right hand column select the 'Help' tab and then the 'Settings' tab beneath. Click on the 'Install/Configure Add-ons' button. This will open the Add-on Manager.***2.1.5.4*** Click the 'Install Add-on' button and select the sbgn-ed.jar file downloaded previously. Click the 'Install' button. This will return you to the 'Add-on Manager'.***2.1.5.5*** A message will appear the top of the Add-on Manager window stating that 'Add-on "sbgn-ed.jar" will be updated when application is restarted'. Select OK and quit the program, before relaunching it.***2.1.5.6*** From the menus at on the top of the VANTED window, select File\>Open and choose your downloaded file with the '.sbgn' file extension, in the usual way.

2.2. Accessing supplementary SBGN-ML files using the Cytoscape software tool {#sec0020}
----------------------------------------------------------------------------

**2.2.1** Download and install Cytoscape from <http://www.cytoscape.org/>.**2.2.2** Open Cytoscape and select the Plugins menu followed by 'Manage Plugins'.**2.2.3** In the search bar, type sbgn and hit return. Folders will appear in the window and under 'Available for install' will appear a Utility folder.**2.2.4** Open the utility folder and select the latest version of CySBGN before hitting the install button. The CySBGN plugin will then be downloaded and installed. Once it is installed, close the 'Manage Plugins' window.**2.2.5** From the File menu select import followed by 'Network (Multiple File Types)'. In the window that opens, make sure that the 'Local' option is chosen and high the 'Select' button to bring up a file selector. Choose the downloaded file with the 'sbgn' file extension in the usual way.

3. Results and discussion {#sec0025}
=========================

3.1. Pathway maps {#sec0030}
-----------------

[Fig. 1](#fig0005){ref-type="fig"} shows the mevalonate arm of the cholesterol biosynthesis pathway and includes enzymatic activity in the mitochondria, peroxisome, cytoplasm and endoplasmic reticulum. The arm starts with the consumption of acetyl-CoA, which occurs in parallel in three cell compartments (the mitochondria, cytoplasm and peroxisome) and terminates with the production of squalene in the endoplasmic reticulum. [Fig. 2](#fig0010){ref-type="fig"} shows the sterol arms of the cholesterol biosynthesis pathway and this includes the Bloch pathway, the Kandutsch-Russell pathway and the shunt pathway. This arm starts with Squalene and terminates with cholesterol production on the Bloch and Kandutsch-Russell pathways and with 24(S),25-epoxycholesterol on the shunt pathway. [Fig. 3](#fig0015){ref-type="fig"} provides a legend for the SBGN schema, explaining the various nodes and edges.

3.2. Mevalonate arm of the cholesterol biosynthesis pathway {#sec0035}
-----------------------------------------------------------

**3.2.1. Acetyl-CoA acetyltransferase (ACAT1; ACAT2;** ***Acetoacetyl-CoA thiolase*****; EC 2.3.1.9)** is an enzyme that catalyzes the reversible condensation of two molecules of acetyl-CoA and forms acetoacetyl-CoA. This reaction is an important step in ketone body formation. Both mitochondrial ACAT1 and cytosolic ACAT2 enzymes are homotetramers [@bib0095; @bib0100]. Kovacs et al. suggest a possibility of distribution of ACAT1 between peroxisomes and mitochondria as experimental evidence supports the formation of acetoacetyl-CoA in peroxisomes [@bib0015]. The proposed step in peroxisomes is shown in [Fig. 1](#fig0005){ref-type="fig"} by a reaction glyph with a question mark. Mutations of the ACAT1 gene cause alpha-methylacetoacetic aciduria, an autosomal recessive disorder [@bib0105].

**3.2.2.** ***Hydroxymethylglutaryl-CoA synthase*** **(HMGCS1; HMGCS2; EC 2.3.3.10)** forms HMG-CoA from acetyl-CoA and acetoacetyl-CoA. The two proteins with this enzymological activity are HMGCS1 and HMGCS2 ([Table 1](#tbl0005){ref-type="table"}). HMGCS1 is a cytoplasmic enzyme and HMGCS2 is localized to mitochondria and peroxisome [@bib0015]. Ortiz and co-authors provide evidence for the involvement of HMGCS2 in producing cholesterol-convertible HMG-CoA [@bib0110]. Peroxisomal localization of this enzyme was subsequently confirmed and the significance of the peroxisomal pathway in cholesterol production was demonstrated [@bib0195; @bib0200]. The schema proposed by Kovacs and co-authors implies that the mitochondrial component of HMG-CoA is being converted into acetyl-CoA and acetoacetate by HMGCL (see 3.2.3) and is not likely to be involved in further steps contributing to cholesterol formation [@bib0015]. The possibility of HMG-CoA transport from the mitochondria to the endoplasmic reticulum or peroxisome requires further study.

**3.2.3.** ***Hydroxymethylglutaryl-CoA lyase, mitochondrial*** **(HMGCL; EC 4.1.3.4)** is a key enzyme in the ketone body formation pathway that provides fuel to extrahepatic tissues [@bib0115]. It transforms HMG-CoA into acetyl-CoA and acetoacetate. HMGCL is a mitochondrial enzyme and Kovacs et al. suggest peroxisomal localization in addition to mitochondrial [@bib0015]. Since the peroxisomal localization is not confirmed yet, we show this step with a question mark on the diagram ([Fig. 1](#fig0005){ref-type="fig"}). The enzyme deficiency (HMGCLD) or hydroxymethylglutaric aciduria may be due to a variety of mutations and can be fatal [@bib0120].

**3.2.4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR; EC 1.1.1.34)** catalyzes the conversion of 3-hydroxy-3-methylglutaryl-CoA into mevalonic acid. The enzyme is highly regulated by relevant signaling pathways that include the SREBP pathway [@bib0125]. Kovacs et al. confirm endoplasmic reticulum localization of HMGCR and provide evidence that suggests peroxisomal localization [@bib0015]. In our model both locations for this enzyme are included. This enzyme is conventionally regarded as being rate limiting in the pathway and its interactions are targeted by the statin class of drug.

**3.2.5. Mevalonate kinase (MVK; ATP:mevalonate 5-phosphotransferase; EC 2.7.1.36)** catalyzes conversion of mevalonate into phosphomevalonate. According to Hogenboom and co-authors [@bib0130; @bib0135; @bib0140; @bib0145] mevalonate kinase (MVK), phosphomevalonate kinase (PMK) and mevalonate pyrophosphate decarboxylase (MVD) are cytosolic enzymes. This contradicts studies of Kovacs and co-authors that confirm their previous findings of peroxisomal localization of the three enzymes [@bib0150] using stable isotopic techniques and human cells [@bib0015]. MVK is regulated by intermediates of the cholesterol metabolism pathway [@bib0155]. MVK can be competitively inhibited by farnesyl- and geranyl-pyrophosphates [@bib0160]. Mutation of the MVK gene causes mevalonate kinase deficiency [@bib0165], a disorder that leads to the lower activity of the enzyme and the accumulation of mevalonic acid, resulting in mevalonic aciduria [@bib0170] and hyperimmunoglobulinemia D syndrome [@bib0175].

**3.2.6. Phosphomevalonate kinase (PMVK; EC 2.7.4.2)** catalyzes formation of mevalonate 5-diphosphate from mevalonate 5-phosphate, an essential step in the mevalonate pathway. It is a reversible reaction and kinetic constants have been determined for human enzymes, both for forward and reverse reactions [@bib0180; @bib0185]. Expression of this enzyme is regulated in response to dietary sterol levels and this regulation is coordinated with HMGCR [@bib0190]. Peroxisomal localization of the enzyme has been confirmed [@bib0015; @bib0150; @bib0190; @bib0195; @bib0200].

**3.2.7. Diphosphomevalonate decarboxylase (MVD; mevalonate (diphospho) decarboxylase; EC 4.1.1.33** is an enzyme that decarboxylates mevalonate 5-diphosphate forming isopentenyl diphosphate while hydrolyzing ATP. This enzyme is considered to be a useful target for lowering serum cholesterol levels [@bib0205] and is active as a homodimer [@bib0205]. Information on peroxisomal localization of diphosphomevalonate decarboxylase is provided in the section on mevalonate kinase (3.2.5).

**3.2.8. Isopentenyl-diphosphate delta-isomerases (IDI1; IDI2; EC 5.3.3.2)** perform isomerization of isopentenyl diphosphate into dimethylallyl diphosphate. These metabolites serve as fundamental building blocks of isoprenoids. This is an essential rate-limiting regulatory step for isoprenoid biosynthesis [@bib0210]. There are two types of isopentenyl-diphosphate delta-isomerase, IDI1 and IDI2. They differ in their structure and activity [@bib0215]. Both enzymes act via a proton addition/elimination mechanism [@bib0220]. IDI2 requires the presence of a reduced flavin mononucleotide cofactor [@bib0215] and both enzymes are localized to the peroxisome [@bib0225].

**3.2.9. Farnesyl diphosphate synthase (FDPS; EC 2.5.1.10; EC 2.5.1.1; Dimethylallyltranstransferase)** catalyzes two reactions that lead to farnesyl diphosphate formation. In the first (EC 2.5.1.1 activity) isopentenyl diphosphate and dimethylallyl diphosphate are transformed into geranyl diphosphate. Next, geranyl diphosphate and isopentenyl diphosphate are transformed into farnesyl diphosphate (EC 2.5.1.10 activity). The enzyme is a homodimer [@bib0230]. It is reported to be localized in peroxisomes [@bib0235]. FDPS supplies precursors for synthesis of steroids, dolichols and ubiquinones, protein fanesylation and geranylation. This enzyme has been suggested as an important target for drug development [@bib0240].

**3.2.10. Geranylgeranyl pyrophosphate synthase (GGPS1; EC 2.5.1.29; EC 2.5.1.10; farnesyl diphosphate synthase; EC 2.5.1.1; dimethylallyltranstransferase)** is able to catalyze the two reactions of farnesyl diphosphate formation. In addition, the enzyme catalyzes the addition of three molecules of isopentenyl diphosphate to dimethylallyl diphosphate and forms geranylgeranyl diphosphate, an important precursor of geranylated proteins [@bib0245] (EC 2.5.1.29 activity). The active enzyme is homohexamer [@bib0245] and is assumed to be localized to the endoplasmic reticulum.

**3.2.11. Farnesyl-diphosphate farnesyltransferase 1 (FDFT1; EC 2.5.1.21; Squalene synthase)** catalyzes a two-step reductive dimerization of two farnesyl diphosphate molecules and synthesizes squalene [@bib0250; @bib0255; @bib0260]. The FDFT1 expression level is regulated by cholesterol status: the human FDFT1 gene has a complex promoter with multiple binding sites for SREBP-1a and SREBP-2 [@bib0265].

3.3. Sterol arms of the sterol biosynthesis pathway {#sec0040}
---------------------------------------------------

**3.3.1. Squalene epoxidase (SQLE; EC 1.14.13.132; squalene monooxygenase)** catalyzes the conversion of squalene into squalene-2,3-epoxide and the conversion of squalene-2,3-epoxide (2,3-oxidosqualene) into 2,3:22,23-diepoxysqualene (2,3:22,23-dioxidosqualene). The first reaction is the first oxygenation step in the cholesterol biosynthesis pathway and the second reaction is the first step in 24(S),25-epoxycholesterol formation from squalene-2,3-epoxide [@bib0020; @bib0270]. The steps are localized to the endoplasmic reticulum membrane [@bib0275] and it has been suggested that this is one of the rate-liming steps in the pathway [@bib0280].

**3.3.2. Lanosterol synthase (LSS; OLC; OSC; 2,3-oxidosqualene:lanosterol cyclase; EC 5.4.99.7)** catalyzes cyclization of squalene-2,3-epoxide to lanosterol and 2,3:22,23-diepoxysqualene to 24(S),25-epoxylanosterol [@bib0020; @bib0270]. The active monomeric enzyme is localized to the endoplasmic reticulum membrane [@bib0285]. Together with FDFT1 and SQLE, LSS has been considered as prospective target for antihypercholesterolemia drugs as an alternative to statin-based therapies [@bib0290; @bib0295].

**3.3.3. Delta(24)-sterol reductase (DHCR24; 24-dehydrocholesterol reductase; EC 1.3.1.72)** is a special enzyme in cholesterol biosynthesis pathway due to its broad substrate specificity. It catalyzes the reduction of the delta-24 double bond of intermediate metabolites. In particular, DHCR24 converts lanosterol into 24,25-dihydrolanostrol, the initial metabolite of the Kandutsch-Russell pathway, and also provides the last step of Bloch pathway converting desmosterol into cholesterol. Intermediates of the Bloch pathway are converted by DHCR24 into intermediates of Kandutsch-Russell pathway [@bib0020]. Endoplasmic reticulum membrane localization has been confirmed for the enzyme [@bib0300]. Recent studies investigating the regulation of the DHCR24 promoter present evidence of binding sites for SREBP-2 [@bib0305; @bib0310]. DHCR24 participates in the inflammatory response and induces heme oxigenase-1, a potentially cardioprotective enzyme [@bib0315]. Mutations in the DHCR24 gene causes desmosterolosis [@bib0320], a rare autosomal disorder that is characterized by elevated level of desmosterol in tissues [@bib0325].

**3.3.4. Lanosterol 14-alpha demethylase (CYP51A1; cytochrome P450, family 51, subfamily A, polypeptide 1; EC 1.14.13.70)** converts lanosterol into 4,4-dimethyl-5α-cholesta-8,14,24-trien-3β-ol and 24,25-dihydrolanosterol into 4,4-dimethyl-5α-cholesta-8,14-dien-3β-ol in three steps [@bib0040].

**3.3.5. Delta(14)-sterol reductase (TM7SF2; transmembrane 7 superfamily member 2; EC 1.3.1.70)** catalyzes reactions on the three branches of the cholesterol and 24(S),25-epoxycholesterol pathways [@bib0020; @bib0040]. This enzyme is localized to the endoplasmic reticulum membrane [@bib0330].

**3.3.6. Methylsterol monooxygenase 1 (MSMO1; SC4MOL;** ***C-4 methylsterol oxidase*****; EC 1.14.13.72)** catalyzes demethylation of C4-methylsterols [@bib0040]. This protein is localized to the endoplasmic reticulum membrane [@bib0335]. Mutations in the MSMO1 gene cause psoriasiform dermatitis, microcephaly and developmental delay [@bib0340].

**3.3.7. Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (NSDHL; NAD(P) dependent steroid dehydrogenase-like; EC 1.1.1.170)** participates in several steps of post-squalene cholesterol and 24(S),25-epoxycholesterol synthesis [@bib0020; @bib0040]. Defects in the NSDHL gene cause CK syndrome [@bib0345], recessive mental retardation syndrome [@bib0350] and CHILD syndrome [@bib0355], congenital hemidysplasia with ichythyosiform erythrodema and limb defects [@bib0360].

**3.3.8. 3-keto-steroid reductase (HSD17B7; 17-beta-hydroxysteroid dehydrogenase 7; EC 1.1.1.270)** was the last unknown enzyme of mammalian cholesterol biosynthesis [@bib0365]. It was previously reported in the regulation of the activity of sex steroids [@bib0020; @bib0040; @bib0365; @bib0370]. It converts zymosterone into zymosterol in the Bloch pathway.

**3.3.9. 3-Beta-hydroxysteroid-delta(8),delta(7)-isomerase (EBP; emopamil-binding protein; EC 5.3.3.5)** catalyzes the conversion of delta(8)-sterols into delta(7)-sterols. Mutations in the EBP gene cause Conradi-Hunermann-Happle syndrome [@bib0375] characterized by punctiform calcification in the bones [@bib0380; @bib0385]. It is an endoplasmic reticulum membrane localized protein [@bib0390].

**3.3.10. Lathosterol oxidase (SC5DL; Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like; EC 1.14.21.6)** catalyzes the production of 7-dehydrocholesterol, 7-dehydrodesmosterol and 24(S),25-epoxy-7-dehydrocholesterol [@bib0025]. Endoplasmic reticulum membrane localization has been suggested [@bib0395]. Lanosterol side chain amines were reported to be selective inhibitors for lathosterol oxidase [@bib0400] and together with other inhibitors for the post-squalene enzymes of the cholesterol biosynthesis pathway were suggested as potential targets for therapies to reduce the risk of cardiovascular disease [@bib0405]. Defects in the enzyme are the cause of lathosterolosis [@bib0410], an autosomal recessive disorder that is characterized by multiple congenital anomalies and liver disease [@bib0415].

**3.3.11. 7-Dehydrocholesterol reductase (DHCR7; EC 1.3.1.21)** catalyses reduction of the C7--C8 double bond of 7-dehydrocholesterol and formation of cholesterol. It also produces desmosterol from 7-dehydrodesmosterol [@bib0040] and 24(S),25-epoxycholesterol from 24(S),25-epoxy-7-dehydrocholesterol [@bib0020]. Mutations in the gene that encodes DHCR7 causes Smith-Lemli-Opitz syndrome, a recessively inherited autosomal disease [@bib0420].

**3.3.12. Cytochrome P450, family 3, subfamily A, polypeptide 4 (CYP3A4; 1,8-cineole 2-exo-monooxygenase; taurochenodeoxycholate 6α-hydroxylase; EC 1.14.13.97)** catalyses the hydroxylation of cholesterol leading to 25-hydroxycholesterol [@bib0425] and 4β-hydroxycholesterol [@bib0430; @bib0435]. It is localized to the endoplasmic reticulum [@bib0440].

**3.3.13. Cholesterol 25-hydroxylase (CH25H; Cholesterol 25-monooxygenase; EC 1.14.99.38)** uses di-iron cofactors to catalyze the hydroxylation of cholesterol [@bib0445; @bib0450; @bib0455] to produce 25-hydroxycholesterol. Has the capacity to catalyze the transition of 24-hydroxycholesterol to 24,25-dihydroxycholesterol. It is an endoplasmic reticulum localized enzyme [@bib0445] and has been shown to have a role in innate immunity [@bib0005; @bib0010]. Mutations have been associated with Alzheimer\'s disease [@bib0460; @bib0465].

**3.3.14. Cytochrome P450, family 7, subfamily A, polypeptide 1 (CYP7A1; cholesterol 7-alpha-hydroxylase; EC 1.14.13.17)** responsible for introducing a hydrophilic moiety at position 7 of cholesterol to form 7α-hydroxycholesterol [@bib0470]. It is localized to the endoplasmic reticulum [@bib0475].

**3.3.15. Cytochrome P450, family 27, subfamily A, polypeptide 1 (CYP27A1; Sterol 27-hydroxylase; EC 1.14.13.15)** was the first hydroxylase to be isolated [@bib0480]. It catalyses the transition of mitochondrial cholesterol to 27-hydroxycholesterol [@bib0485] and 25-hydroxycholesterol [@bib0490; @bib0495]. It is localized to the mitochondria [@bib0485] and mutations are associated with the recessive autosome disorder Cerebrotendinous Xanthomatosis [@bib0500].

**3.3.16. Cytochrome P450 46A1 (CYP46A1, cholesterol 24-hydroxylase, EC 1.14.13.98)** catalyses transformation of cholesterol into 24(S)-hydroxycholesterol. Localized to endoplasmic reticulum membrane [@bib0505], the enzyme is mainly expressed in brain tissue and is considered to be an important biomarker for neurodegenerative disorders [@bib0510; @bib0515; @bib0520; @bib0525].

3.4. Oxysterol 24(S),25-epoxycholesterol synthesis from squalene {#sec0045}
----------------------------------------------------------------

24(S),25-Epoxycholesterol is produced in a shunt pathway that is parallel to the two branches of the cholesterol synthesis pathway [@bib0020; @bib0530; @bib0535; @bib0540]. The same set of enzymes is involved in the formation of cholesterol from 24,25-dihydrolanosterol in the Kandutsch-Russell pathway, desmosterol from lanosterol in the Bloch pathway and 24(S),25-epoxycholesterol from 24(S),25-epoxylanosterol in a shunt pathway [@bib0020]. Due to its importance in regulatory processes 24(S),25-epoxycholesterol is in the focus of several recent publications [@bib0535; @bib0545; @bib0550; @bib0555; @bib0560]. However, further research is necessary to confirm each step of the shunt pathway and the corresponding intermediate metabolites. In our representation, the known intermediates of the shunt pathway are shown and likely missing information is noted with the appropriate SBGN glyph.

3.5. Transport of the intermediate metabolites between different cellular compartments {#sec0050}
--------------------------------------------------------------------------------------

Little is known about transporting of the intermediate metabolites of the cholesterol biosynthesis pathway between different cellular compartments. It is not known whether metabolites in the mitochondria participate in cholesterol biosynthesis and, in a number of cases, it is unclear whether metabolites move between compartments through diffusion or transportation. This is something that should be addressed in the future. It has been suggested that limitations in subcellular fractionation methods are a significant factor in our poor understanding of the subcellular localization of these enzymes [@bib0015].

4. Concluding remarks {#sec0055}
=====================

The diagrams presented here show a comprehensive view of the mevalonate, Kandutsch-Russell, Bloch and shunt pathways. The diagrams are described using the SBGN schema, an open and community developed graphical language for unambiguously capturing pathway structure. Missing/uncertain information is clearly marked on the pathway diagrams and shows the areas that need to be further explored. Models of these diagrams are available as supplementary material in the SBGN-ML and SBML/CellDesigner [@bib0565] file formats for future development and refinement.

We hope that by elucidating and integrating the detailed structure of this pathway, we will contribute to a finer level of understanding of cholesterol metabolism and its function and that this will serve as a useful resource for future studies of the cholesterol biosynthesis pathway.

Appendix A. Supplementary data {#sec0065}
==============================

The following are Supplementary data to this article:

SynthSys Edinburgh is a Center for Integrative Systems Biology funded by BBSRC and EPSRC award no. D019621. This work was supported by the Wellcome Trust programme grant no. WT066784 (to P.G.) WJG is supported by BBSRC (BB/I001735/1).

![The mevalonate arm of the cholesterol biosynthesis pathway presented in SBGN notation. An interactive, parsable version of this figure, encoded using the SBGN-ML file format, is available in the supplementary material. The various glyph are explained in the legend in [Fig. 3](#fig0015){ref-type="fig"}.](gr1){#fig0005}

![The sterol arms of the cholesterol biosynthesis pathway (shunt, Bloch and Kandutsch-Russell) presented in SBGN notation. An interactive, parsable version of this figure, encoded using the SBGN-ML file format, is available in the supplementary material. The various glyph are explained in the legend in [Fig. 3](#fig0015){ref-type="fig"}.](gr2){#fig0010}

![The legend explaining the SBGN glyphs used in [Figs. 2 and 3](#fig0010 fig0015){ref-type="fig"}.](gr3){#fig0015}

###### 

Uniprot IDs for the enzymes in the pathways shown in [Figs. 1 and 2](#fig0005 fig0010){ref-type="fig"}.

  Uniprot ID   Link                                    EC                            Order   Gene name       Protein name                                                                                               Related disease                                              Reference
  ------------ --------------------------------------- ----------------------------- ------- --------------- ---------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ ---------------------------------------------
  P24752       http://www.uniprot.org/uniprot/P24752   2.3.1.9                       1       ACAT1           Acetyl-CoA acetyltransferase, mitochondrial; THIL                                                          Alpha-methylacetoacetic aciduria                             OMIM \#203750
  Q9BWD1       http://www.uniprot.org/uniprot/Q9BWD1   2.3.1.9                       1       ACAT2           Acetyl-CoA acetyltransferase, cytosolic                                                                    ACAT2 deficiency                                             OMIM \#614055
  Q01581       http://www.uniprot.org/uniprot/Q01581   2.3.3.10                      2       HMGCS1          Hydroxymethylglutaryl-CoA synthase, cytoplasmic                                                            Not found                                                    OMIM \#142940
  P54868       http://www.uniprot.org/uniprot/P54868   2.3.3.10                      2       HMGCS2          Hydroxymethylglutaryl-CoA synthase, mitochondrial                                                          HMG-CoA synthase deficiency                                  OMIM \#605911; PMID 16601895
  P35914       http://www.uniprot.org/uniprot/P35914   4.1.3.4                       3       HMGCL           Hydroxymethylglutaryl-CoA lyase, mitochondrial                                                             HMG-CoA lyase deficiency                                     OMIM \#246450; PMID 17692550
  P04035       http://www.uniprot.org/uniprot/P04035   1.1.1.34                      4       HMGCR           3-Hydroxy-3-methylglutaryl-coenzyme A reductase                                                            Not found                                                    OMIM \#142910
  Q03426       http://www.uniprot.org/uniprot/Q03426   2.7.1.36                      5       MVK             Mevalonate kinase                                                                                          Mevalonic aciduria                                           OMIM \#610377; PMID 16722536
  Q15126       http://www.uniprot.org/uniprot/Q15126   2.7.4.2                       6       PMVK            Phosphomevalonate kinase                                                                                   Not found                                                    OMIM \#607622
  P53602       http://www.uniprot.org/uniprot/P53602   4.1.1.33                      7       MVD             Mevalonate diphosphate decarboxylase                                                                       Not found                                                    OMIM \#603236
  Q13907       http://www.uniprot.org/uniprot/Q13907   5.3.3.2                       8       IDI1            Isopentenyl-diphosphate delta-isomerase 1                                                                  Not found                                                    OMIM \#604055
  Q9BXS1       http://www.uniprot.org/uniprot/Q9BXS1   5.3.3.2                       8       IDI2            Isopentenyl-diphosphate delta-isomerase 2                                                                  Not found                                                    Not found
  P14324       http://www.uniprot.org/uniprot/P14324   2.5.1.10; 2.5.1.1             9       FDPS            Farnesyl diphosphate synthase; dimethylallyltranstransferase                                               Not found                                                    Not found
  O95749       http://www.uniprot.org/uniprot/O95749   2.5.1.29; 2.5.1.10; 2.5.1.1   10      GGPS1           Geranylgeranyl pyrophosphate synthase; farnesyl diphosphate synthase; dimethylallyltranstransferase        Not found                                                    Not found
  P37268       http://www.uniprot.org/uniprot/P37268   2.5.1.21                      11      FDFT1           Farnesyl-diphosphate farnesyltransferase 1; squalene synthase                                              Not found                                                    OMIM \#184420
  Q14534       http://www.uniprot.org/uniprot/Q14534   1.14.13.132                   12      SQLE            Squalene monooxygenase; squalene epoxidase                                                                 Not found                                                    OMIM \#602019
  P48449       http://www.uniprot.org/uniprot/P48449   5.4.99.7                      13      LSS             Lanosterol synthase                                                                                        Not found                                                    OMIM \#600909
  Q15392       http://www.uniprot.org/uniprot/Q15392   1.3.1.72                      14      DHCR24          Delta(24)-sterol reductase; 24-dehydrocholesterol reductase                                                Desmosterolosis                                              OMIM \#602398; PMID 21559050
  Q16850       http://www.uniprot.org/uniprot/Q16850   1.14.13.70                    15      CYP51A1         Lanosterol 14-alpha demethylase; cytochrome P450, family 51, subfamily A, polypeptide 1                    Not found                                                    OMIM \#601637
  O76062       http://www.uniprot.org/uniprot/O76062   1.3.1.70                      16      TM7SF2          Delta(14)-sterol reductase; transmembrane 7 superfamily member 2                                           Not found                                                    OMIM \#603414
  Q15800       http://www.uniprot.org/uniprot/Q15800   1.14.13.72                    17      MSMO1; SC4MOL   Methylsterol monooxygenase 1                                                                               Psoriasiform dermatitis; microcephaly; developmental delay   PMID 21285510
  Q15738       http://www.uniprot.org/uniprot/Q15738   1.1.1.170                     18      NSDHL           Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating; NAD(P) dependent steroid dehydrogenase-like   CK syndrome; CHILD syndrome                                  OMIM \#300831; PMID 21129721; OMIM \#308050
  P56937       http://www.uniprot.org/uniprot/P56937   1.1.1.270                     19      HSD17B7         3-Keto-steroid reductase; 17-beta-hydroxysteroid dehydrogenase 7                                           Not found                                                    OMIM \#606756
  Q15125       http://www.uniprot.org/uniprot/Q15125   5.3.3.5                       20      EBP             3-Beta-hydroxysteroid-delta(8),Delta(7)-isomerase; emopamil-binding protein                                Conradi-Hünermann-Happle syndrome                            OMIM \#302960; PMID 21163155; PMID 22229330
  O75845       http://www.uniprot.org/uniprot/O75845   1.14.21.6                     21      SC5DL           Lathosterol oxidase; sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like            Lathosterolosis                                              OMIM \#607330; PMID 12189593
  Q9UBM7       http://www.uniprot.org/uniprot/Q9UBM7   1.3.1.21                      22      DHCR7           7-Dehydrocholesterol reductase                                                                             Smith-Lemli-Opitz syndrome (SLOS)                            OMIM \#270400; PMID 23059950; PMID 23042628
  P08684       http://www.uniprot.org/uniprot/P08684   1.14.13.97                    23      CYP3A4          Cytochrome P450 3A4                                                                                        Not found                                                    OMIM \#124010
  O95992       http://www.uniprot.org/uniprot/O95992   1.14.99.38                    24      CH25H           Cholesterol 25-hydroxylase                                                                                 Alzheimer\'s disease                                         OMIM \#604551; PMID 20580938; PMID 16909003
  P22680       http://www.uniprot.org/uniprot/P22680   1.14.13.17                    25      CYP7A1          Cholesterol 7-alpha-monooxygenase                                                                          Not found                                                    OMIM \#118455
  Q02318       http://www.uniprot.org/uniprot/Q02318   1.14.13.15                    26      CYP27A1         Sterol 26-hydroxylase, mitochondrial                                                                       Cerebrotendinous xanthomatosis                               OMIM \#606530; PMID 2019602; PMID 8514861
  Q9Y6A2       http://www.uniprot.org/uniprot/Q9Y6A2   1.14.13.98                    27      CYP46A1         Cholesterol 24-hydroxylase                                                                                 Alzheimer\'s disease                                         OMIM \#604087; PMID 12533085; PMID 12533083

###### 

Systematics names, common names (where available) and LipidMaps IDs for the metabolites shown in [Figs. 1 and 2](#fig0005 fig0010){ref-type="fig"}.

  Pathway                                              LM_ID            Common Name                            Systematic Name
  ---------------------------------------------------- ---------------- -------------------------------------- ---------------------------------------------------------------------------
  Lanosterol biosynthesis                              LMFA07050029     Acetyl-CoA                             Acetyl-CoA
  Lanosterol biosynthesis                              LMFA07050030     Acetoacetyl-CoA                        Acetoacetyl-CoA
  Lanosterol biosynthesis                              LMFA07050028     HMG-CoA                                3S-Hydroxy-3-methyl-glutaryl CoA
  Lanosterol biosynthesis                              LMFA01050352     Mevalonic acid                         3R-Methyl-3,5-dihydroxy-pentanoic acid
  Lanosterol biosynthesis                              LMFA01050415     Mevalonate-P                           3R-Methyl-3-hydroxypentanoic acid 5-phosphate
  Lanosterol biosynthesis                              LMFA01050416     Mevalonate-PP                          3R-Methyl-3-hydroxypentanoic acid 5-diphosphate
  Lanosterol biosynthesis                              LMPR01010008     Isopentenyl-diphosphate                3-Methylbut-3-enyl pyrophosphate
  Lanosterol biosynthesis                              LMPR01010001     Dimethylallyl-diphosphate              3-Methylbut-2-enyl pyrophosphate (dimethylallyl-diphosphate)
  Lanosterol biosynthesis                              LMPR0102010001   Geranyl diphosphate                    Geranyl pyrophosphate
  Lanosterol biosynthesis                              LMPR0103010002   Farnesyl diphosphate                   Farnesyl pyrophosphate
  Lanosterol biosynthesis                              LMPR0106010003   Presqualene diphosphate                Presqualene diphosphate
  Lanosterol biosynthesis                              LMPR0106010002   Squalene                               Squalene
  Lanosterol biosynthesis                              LMPR0106010010   3S-Squalene-2,3-epoxide                2,3S-Epoxy-2,6,10,15,19,23-hexamethyltetracosa-6E,10E,14E,18E,22-pentaene
  Lanosterol biosynthesis                              LMST01010017     Lanosterol                             Lanosta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010124     32-Hydroxylanosterol                   4,4-Dimethyl-14α-hydroxymethyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010222     32-oxolanosterol                       4,4-Dimethyl-14α-formyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010149     4,4-dimethylcholesta-8,11,24-trienol   4,4-Dimethyl-5α-cholesta-8,14,24-trien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010176     14-demethyllanosterol                  4,4-Dimethyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010232     not available                          4α-Hydroxymethyl-4β-methyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010229     not available                          4α-Formyl-4β-methyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010150     4α-carboxy-4β-methyl-zymosterol        4α-Carboxy-4β-methyl-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010237     3-Keto-4α-methyl-zymosterol            4α-Methyl-5α-cholesta-8,24-dien-3-one
  Cholesterol biosynthesis (Bloch)                     LMST01010151     4α-Methyl-zymosterol                   4α-Methyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010234     Not available                          4α-Hydroxymethyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010226     Not available                          4α-Formyl-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010152     4α-Carboxy-zymosterol                  4α-Carboxy-5α-cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010168     Zymosterone                            5α-Cholesta-8,24-dien-3-one
  Cholesterol biosynthesis (Bloch)                     LMST01010066     Zymosterol                             5α-Cholesta-8,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010206     5α-Cholesta-7,24-dien-3β-ol            5α-Cholesta-7,24-dien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010121     7-Dehydro-desmosterol                  Cholest-5,7,24-trien-3β-ol
  Cholesterol biosynthesis (Bloch)                     LMST01010016     Desmosterol                            Cholest-5,24-dien-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010087     24,25-Dihydrolanosterol                5α-Lanost-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010224     Not available                          4,4-Dimethyl-14α-hydroxymethyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010223     Not available                          4,4-Dimethyl-14α-formyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010277     Not available                          4,4-Dimethyl-5α-cholesta-8,14-dien-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010225     Not available                          4,4-Dimethyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010233     Not available                          4α-Hydroxymethyl-4β-methyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010230     Not available                          4α-Formyl-4β-methyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010227     Not available                          4α-Carboxy-4β-methyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010236     Not available                          4α-Methyl-5α-cholest-8-en-3-one
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010197     4α-Methylcholest-8-en-3β-ol            4α-Methyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010235     Not available                          4α-Hydroxymethyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010231     Not available                          4α-Formyl-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010228     Not available                          4α-Carboxy-5α-cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010239     Not available                          5α-Cholest-8-en-3-one
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010096     Zymostenol                             5α-Cholest-8-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010089     Lathosterol                            Cholest-7-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010069     7-Dehydrocholesterol                   Cholesta-5,7-dien-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell)         LMST01010001     Cholesterol                            Cholest-5-en-3β-ol
  Cholesterol biosynthesis (Kandustch-Russell/Bloch)   LMST01010018     25-Hydroxy-cholesterol                 Cholest-5-en-3β,25-diol
  Cholesterol biosynthesis (Kandustch-Russell/Bloch)   LMST01010014     4β-Hydroxy-cholesterol                 Cholest-5-en-3β,4β-diol
  Cholesterol biosynthesis (Kandustch-Russell/Bloch)   LMST01010013     7α-Hydroxy-cholesterol                 Cholest-5-en-3β,7α-diol
  Cholesterol biosynthesis (Kandustch-Russell/Bloch)   LMST01010057     27-Hydroxy-cholesterol                 Cholest-5-en-3β,26-diol
  Cholesterol biosynthesis (Kandustch-Russell/Bloch)   LMST01010164     24-Hydroxy-cholesterol                 Cholest-5-en-3β,24-diol

[^1]: Joint first authors.
